Logo image of ALI2S.PA

I2S SA (ALI2S.PA) Stock Earnings & Estimates

EPA:ALI2S - FR0005854700 - Common Stock

6.95 EUR
+0.65 (+10.32%)
Last: 9/8/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
ALI2S.PA revenue by date.ALI2S.PA revenue by date.
16.712M
-9.41%
17.517M
4.82%
18.341M
4.71%
EBITDA
YoY % growth
ALI2S.PA ebitda by date.ALI2S.PA ebitda by date.
N/A1.119M1.243M
11.13%
EBIT
YoY % growth
ALI2S.PA ebit by date.ALI2S.PA ebit by date.
390.4K
-52.76%
752.2K
92.67%
775K
3.03%
Operating Margin
ALI2S.PA operating margin by date.ALI2S.PA operating margin by date.
2.34%4.29%4.23%
EPS
YoY % growth
ALI2S.PA eps by date.ALI2S.PA eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
9.528M
-5.69%
%
Q2 2024
Q2Q % growth
8.813M
18.88%
%
Q4 2023
Q2Q % growth
10.103M
60.41%
%
Q2 2023
Q2Q % growth
7.414M
-28.81%
%
Q4 2022
Q2Q % growth
6.298M
-37.75%
%
Q2 2022
Q2Q % growth
10.414M
25.02%
%
Q4 2021
Q2Q % growth
10.117M
45.36%
%
Q2 2021
Q2Q % growth
8.33M
29.95%
%
Q4 2020
Q2Q % growth
6.96M
-23.71%
%
Q2 2020
Q2Q % growth
6.41M
-17.78%
%
ALI2S.PA Yearly Revenue VS EstimatesALI2S.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A